Joseph C. Scodari

Joseph C. Scodari is a declared insider at 2 companies (senior executive); the most frequent names are OptiNose, Inc. and Acurx Pharmaceuticals, Inc. We count 7 filings; the first trade dates from 12 December 2018 and the latest from 6 January 2025.

On the market, this insider has only ever bought: 7 purchases, €183k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2025, the count stands at 1 purchase and no sales.

The median purchase comes to €25k. Clusters matter here: 4 out of 7 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

Most recently, on 8 January 2025, the filings show an open-market purchase worth €24k in Acurx Pharmaceuticals, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.